Carboxypeptidase E

CPE
Identifiers
Aliases	CPE, CPH, carboxypeptidase E, IDDHH, BDVS
External IDs	OMIM: 114855 MGI: 101932 HomoloGene: 48052 GeneCards: CPE
Gene location (Human) Chr. Chromosome 4 (human) Band 4q32.3 Start 165,361,194 bp End 165,498,547 bp
Gene location (Mouse) Chr. Chromosome 8 (mouse) Band 8 B3.1|8 32.3 cM Start 65,045,576 bp End 65,146,088 bp
RNA expression pattern Bgee Human Mouse (ortholog) Top expressed in caudate nucleus nucleus accumbens amygdala putamen external globus pallidus prefrontal cortex dorsolateral prefrontal cortex cerebellar vermis Brodmann area 9 entorhinal cortex Top expressed in cingulate gyrus ventral tegmental area subiculum nucleus accumbens habenula paraventricular nucleus of hypothalamus medial geniculate nucleus prefrontal cortex retinal pigment epithelium medial dorsal nucleus More reference expression data BioGPS More reference expression data
Gene ontology Molecular function zinc ion binding metal ion binding neurexin family protein binding peptidase activity carboxypeptidase activity hydrolase activity metallopeptidase activity cell adhesion molecule binding metallocarboxypeptidase activity serine-type carboxypeptidase activity Cellular component synaptic membrane Golgi apparatus secretory granule membrane membrane plasma membrane transport vesicle membrane secretory granule extracellular region neuronal cell body extracellular exosome cytoplasmic vesicle nucleus extracellular space transport vesicle Biological process protein localization to membrane insulin processing cardiac left ventricle morphogenesis Wnt signaling pathway proteolysis metabolism neuropeptide signaling pathway peptide metabolic process protein processing peptide hormone secretion protein localization to secretory granule Sources:Amigo / QuickGO
Orthologs Species Human Mouse Entrez 1363 12876 Ensembl ENSG00000109472 ENSMUSG00000037852 UniProt P16870 Q00493 RefSeq (mRNA) NM_001873 NM_013494 RefSeq (protein) NP_001864 NP_038522 Location (UCSC) Chr 4: 165.36 – 165.5 Mb Chr 8: 65.05 – 65.15 Mb PubMed search
Wikidata
View/Edit Human View/Edit Mouse

Carboxypeptidase E (CPE), also known as carboxypeptidase H (CPH) and enkephalin convertase, is an enzyme that in humans is encoded by the CPE gene. This enzyme catalyzes the release of C-terminal arginine or lysine residues from polypeptides.

CPE is involved in the biosynthesis of most neuropeptides and peptide hormones. The production of neuropeptides and peptide hormones typically requires two sets of enzymes that cleave the peptide precursors, which are small proteins. First, proprotein convertases cut the precursor at specific sites to generate intermediates containing C-terminal basic residues (lysine and/or arginine). These intermediates are then cleaved by CPE to remove the basic residues. For some peptides, additional processing steps, such as C-terminal amidation, are subsequently required to generate the bioactive peptide, although for many peptides the action of the proprotein convertases and CPE is sufficient to produce the bioactive peptide.

Tissue distribution

Carboxypeptidase E is found in brain and throughout the neuroendocrine system, including the endocrine pancreas, pituitary, and adrenal gland chromaffin cells. Within cells, carboxypeptidase E is present in the secretory granules along with its peptide substrates and products. Carboxypeptidase E is a glycoprotein that exists in both membrane-associated and soluble forms. The membrane-binding is due to an amphiphilic α-helix within the C-terminal region of the protein.

Species distribution

Carboxypeptidase E is found in all species of vertebrates that have been examined, and is also present in many other organisms that have been studied (nematode, sea slug). Carboxypeptidase E is not found in the fruit fly (Drosophila), and another enzyme (presumably carboxypeptidase D) fills in for carboxypeptidase E in this organism. In humans, CPE is encoded by the CPE gene.

Function

Carboxypeptidase E functions in the production of nearly all neuropeptides and peptide hormones. The enzyme acts as an exopeptidase to activate neuropeptides. It does that by cleaving off basic C-terminal amino acids, producing the active form of the peptide. Products of carboxypeptidase E include insulin, the enkephalins, vasopressin, oxytocin, and most other neuroendocrine peptide hormones and neuropeptides.

It has been proposed that membrane-associated carboxypeptidase E acts as a sorting signal for regulated secretory proteins in the trans-Golgi network of the pituitary and in secretory granules; regulated secretory proteins are mostly hormones and neuropeptides. However, this role for carboxypeptidase E remains controversial, and evidence shows that this enzyme is not necessary for the sorting of regulated secretory proteins.

Clinical significance

Mice with mutant carboxypeptidase E, Cpe^fat, display endocrine disorders like obesity and infertility. In some strains of mice, the fat mutation also causes hyperproinsulinemia in adult male mice, but this is not found in all strains of mice. The obesity and infertility in the Cpe^fat mice develop with age; young mice (<8 weeks of age) are fertile and have normal body weight. Peptide processing in Cpe^fat mice is impaired, with a large accumulation of peptides with C-terminal lysine and/or arginine extensions. Levels of the mature forms of peptides are generally reduced in these mice, but not eliminated. It is thought that a related enzyme (carboxypeptidase D) also contributes to neuropeptide processing and gives rise to the mature peptides in the Cpe^fat mice.

Mutations in the CPE gene are not common within the human population, but have been identified. One patient with extreme obesity (Body Mass Index >50) was found to have a mutation that deleted nearly the entire CPE gene. This patient had intellectual disability (inability to read or write) and had abnormal glucose homeostasis, similar to mice lacking CPE activity.

In obesity, high levels of circulating free fatty acids have been reported to cause a decrease in the amount of carboxypeptidase E protein in pancreatic beta-cells, leading to beta-cell dysfunction (hyperproinsulinemia) and increased beta-cell apoptosis (via an increase in ER stress). However, because CPE is not a rate-limiting enzyme for the production of most neuropeptides and peptide hormones, it is not clear how relatively modest decreases in CPE activity can cause physiological effects.

See also

• Carboxypeptidase
• Carboxypeptidase A

Further reading

External links

• The MEROPS online database for peptidases and their inhibitors: M14.005
• Carboxypeptidase+E at the U.S. National Library of Medicine Medical Subject Headings (MeSH)